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1  |  CHRONIC LONG -  COVID SYNDROME
Long- COVID syndrome is a complex chronic clinical manifesta-
tion of signs and symptoms in patients who have experienced 
the SARS- CoV- 2 infection without complete recovery from the 
COVID- 19.
A growing fraction of the COVID- 19 patients are emerging with 
continuing effects of the disease, with complaints like mental fog, 
delayed latent periods in recalling events of the recent past, tachy-
cardia, and extreme fatigue.1 In the case where Long- COVID syn-
drome is not observed after SARS- CoV- 2 infections, patients have 
been reported to turn asymptomatic before or within 8– 12 weeks 
after COVID- 19. There have been attempts to draw a timeline for 
Long- COVID and clinical findings persisting beyond 3 weeks after 
the acute short phase was recommended to be considered for Long- 
COVID syndrome2 though cases are appearing even 3 months after 
the acute phase of COVID- 19.
2  |  NEUROLOGIC AL DYSFUNC TIONS IN 
LONG -  COVID
Infections caused by SARS- CoV- 2 have not only resulted in a gigantic 
number of morbidities and mortalities worldwide in COVID- 19, but 
its ability to cause a protracted illness in form of long- COVID is now 
becoming increasingly evident.2 The syndromic manifestation in long- 
COVID has shown to become chronic and the affected individuals are 
seen to be predominately exhibiting neurological deficits which are 
worrying. The most daunting task in long- COVID is to understand the 
mechanisms underlying mechanism in general and the pathogenesis of 
neurological signs and symptoms in particular. Debated here are local 
routes and systemic mechanisms by which SARS- CoV- 2 can involve 
the nervous system to evoke a low- grade smoldering neuronal injury 
that possibly contributes to the neurological deficits reported. A bet-
ter understanding of the route and pathways of the SARS- CoV- 2 in the 
causation of the neurological deficits is expected to develop targeted 
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Abstract
After almost a year of COVID- 19, the chronic long- COVID syndrome has been rec-
ognized as an entity in 2021. The patients with the long- COVID are presenting with 
ominous neurological deficits that with time are becoming persistent and are causing 
disabilities in the affected individuals. The mechanisms underlying the neurological 
syndrome in long- COVID have remained obscure and need to be actively researched 
to find a resolution for the patients with long- COVID. Here, the factors like site of 
viral load, the differential immune response, neurodegenerative changes, and inflam-
mation as possible causative factors are debated to understand and investigate the 
pathogenesis of neuro- COVID in long- COVID syndrome.
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therapies in long- COVID syndrome to minimize the disabilities resulting 
in the affected patients. Additionally, a history of pre- COVID existing 
neurological deficit should be taken into account to identify newer neu-
rological sign and symptoms caused by COVID. A differential diagnosis 
with post- traumatic stress disorder (PTSD) caused by the pandemic ap-
pears to be important.
Also feature like facial drooping, and speech- related deficits 
which are potential signs of stroke can be blunted by a patient's face 
mask, wearing of which is common during the COVID- 19 pandemic.3
3  |  SITES OF VIR AL LOAD AND THEIR 
SIGNIFIC ANCE IN NEURO -  COVID
Central to the understanding of the neurological deficits caused by 
SARS- CoV- 2 is the ability of this virus to seed specific sites in human 
tissues, which can enable its access to the central nervous system 
(CNS). Nasal and oral cavity are known sites of SARS- CoV- 2 seed-
ing from which samples are collected to diagnose COVID- 19. The 
nasal cavity, in particular, is anatomically extended to regions bear-
ing neurological tissues like olfactory mucosa (OM), and across the 
cribriform plate, at the root of the nose (Figure 1A), to the olfactory 
bulb (OB) and frontal lobe of the brain (Figure 1A- A1). Though the 
oral cavity has no direct extensions to the CNS, the infection of the 
nerve terminals in the mouth via retrograde neuronal transport can 
enable the SARS- CoV- 2 to reach cardinal regions of the CNS like the 
brainstem (Figure 1A).2 Common to both of the above routes is its 
extension to the lungs (Figure 1B), which is a known organ to be 
involved in SARS- CoV- 2 infection in acute as well as long- COVID.
4  |  PROGRESSIVE NEUROTROPIC 
DEGENER ATIVE EFFEC TS OF SARS-  CoV- 2
One of the possible reasons for the observation of neurological defi-
cits in long- COVID4 (Figure 1C), is a possibly a slowly progressive de-
generative effect of the SARS- CoV- 2 following the neuronal entry. 
Such finding has been reported recently to affected patients and it 
should be no surprise to see the degenerative processes5 (Figure 1, 
C1), reflecting as neurological deficits. Though the underlying mech-
anisms leading to neuronal damage are yet to be completely under-
stood, neuronal atrophy, hypometabolism, and defects induced in 
synaptic transmission can be the covert pathways induced by SARS- 
CoV- 2 in long- COVID to inflict neuronal damage.
5  |  POSSIBLE ROLE OF THE 
INFL AMMATORY RESPONSE TO SARS- 
CoV- 2 INFEC TION IN C AUSATION OF THE 
CNS MANIFESTATION IN LONG -  COVID
The immunologically mediated cytokine release by glia and lympho-
cytes at the site of viral load and infection may offer an additional if 
not the only reason behind protracted neurological signs and symp-
toms seen in long- COVID. The inflammation (Figure 1, C2) around 
the OM, cribriform plate, and OB to the presence of SARS- CoV- 26 
could become the basis of continuation of anosmia and hypogeusia 
in long- COVID. Similar mechanisms involving the regions around the 
frontal lobe (Figure 1, A) (in proximity to the olfactory bulbs) with 
a sub- clinical low- grade inflammation can be the possible basis of 
“brain fog,” cognitive functional deficits, persistent headaches, and 
diverse neurological findings (Figure 1C) seen in long- COVID.
6  |  DIFFERENTIAL SYNDROMIC 
MANIFESTATION IN NEURO -  COVID
The neurological deficits exhibited in COVID- 19 are known to differ 
widely among the patients infected with SARS- CoV- 2. One exam-
ple is loss of smell (anosmia) and altered sense of taste (hypogeusia), 
presence or absence of seizures, loss of consciousness, and difficul-
ties with involuntary breathing mechanics, which vary in their inten-
sity from patient to patient. Also, the fact that a significant number 
of patients never enter the long- COVID phase needs to be investi-
gated and understood in- depth. The extent of the viral load and CNS 
entry along with differential immune response among the affected 
patients may explain these disparities observed and could be the 
basis of the protracted course of COVID- 19 in that becomes chronic 
to manifest as long- COVID.7 Mechanisms in particular where an in-
complete clearance of the SARS- CoV- 2 is involved can linger on for 
months and its clearance might help as supported by the findings 
in 30 to 40% of those who get the vaccine have reported improve-
ments to their symptoms. The fact that vaccination provokes the 
formation of antibodies and T- killer cells, which may clear the re-
sidual SARS- CoV- 2 from the body, appears to be one possible reason 
and an explanation for the improvements mentioned above in the 
neurological signs and symptoms of long- COVID.
7  |  PERSISTENCE OF VIR AL LOADS AT 
IMMUNOLOGIC ALLY PRIVILEGED SITES
Among diverse reasons for incomplete clearance of SARS- CoV- 2 
from the human body by the immune system after 2– 3 weeks of the 
COVID- 19 infection is the possible ability of the virus to reside at im-
munologically privileged sites, from where its arrival into the circula-
tion can lead to a protracted course of illness leading to long- COVID. 
The eyes, lacrimal sac,8 testes, and placenta are few examples where 
SARS- CoV- 2 can conceal itself, but why this is not the case with pa-
tient's not exhibiting long- COVID remains to be resolved.
8  |  DISCUSSION AND CONCLUSION
The magnitude with which the human immune system would re-
spond to COVID- 19 differs from person to person for few apparent 
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reasons, that includes, (a) the viral load, (b) the ACE2 expression lev-
els in the tissues, and (c) the diversity of immune response.9 It ap-
pears that following an acute phase if the removal of SARS- CoV- 2 
is not substantial enough, the sub- acute infection persists and be-
comes chronic to exhibit as long- COVID. Of the sites that suffer the 
effects of the residual virus and the inflammation that accompanies 
it, the CNS is the most venerable tissue. The latter is because of the 
inability of the neurons to regenerate following damage caused by 
either the virus (Figure 1, C1) or cytokines generated by the low- 
grade inflammation (Figure 1, C2). Other tissues that can regener-
ate following the cellular injury, do not dominate the symptomatic 
picture of long- COVID as a partial restoration of function is likely 
following COVID- 19. The finding that vaccinations help some pa-
tients with long- COVID,7 needs in- depth research to find the sup-
port the vaccination offers to a chronic symptomatic long- COVID 
patient at the pathogenetic level. Stimulation of a weakly provoked 
immune system to eradicate the virus seems to be one possibility, 
but other mechanisms may be at play that is yet to be elucidated 
in long- COVID. The neurological deficits in long- COVID4 were pre-
dicted to impose a huge burden on the healthcare profession and it 
now is proving itself a major cause of disability in the post- acute- 
COVID patient group.
9  |  FUTURE DIREC TIONS
Research that includes long- COVID patients with neurological defi-
cits for understanding the basic underlying pathogenesis of neuro- 
COVID is needed and the NeuroCOVID project is one example.4 The 
biological fluids of these patients need to be fully analyzed for cy-
tokines. Imaging the CNS to notice morphological changes induced 
in long- COVID is also required as the images can be compared in the 
coming years to see if the findings progress or remain static. Clinical 
assessment and appropriate treatment regimens are also essentially 
needed as if not halted in time, the neurological deficits may become 
a permanent disability that would not revert.
F I G U R E  1  Long- COVID: CNS Access and NeuroCOVID syndrome. SARS- CoV- 2 viral loads can follow anatomical pathways from the nasal 
cavity to the brain (A- A1) via the cribriform plate of the ethmoid bone (A1) and the lungs via respiratory passages (B). Patients in long- COVID 
report diverse neurological signs and symptoms (C- list) that can be due to slow neuronal damage (C1) (neurodegeneration) or due to low- 
grade inflammation and cytokine- mediated damage (C2). SARS- CoV- 2 has been isolated from beneath the cribriform plate and the neurons 
of the frontal lobe in COVID- 19 patients
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